Total SA

Total SA is still focused on its plans to sell its 13% stake in Sanofi-Aventis. The company however seems in no hurry as the Chairman Thierry Desmarest told a shareholders meeting, "The general feeling we have is that the market undervalues Sanofi so there is no reason to act in a hurry by selling." He added, "But our objective is not to keep the stake indefinitely. We will try to find the best conditions to sell."